Welcome to iDiagnostix
Revolutionising the science of autism screening through advanced biochemistry.
iDiagnostix is a UK-based biotechnology company developing innovative diagnostic tools that help identify autism spectrum disorder (ASD) using objective, biological markers.
Our Flagship Diagnostic test – ASDproteinpatterntm
The ASDproteinpattern™ blood test is a pioneering tool for the screening of autism spectrum disorder (ASD).
It analyses patterns of naturally occurring (endogenous) modifications in blood proteins, interpreted through an artificial intelligence (AI)–driven diagnostic algorithm that identifies the most predictive biomarker combinations and their optimal weighting.
In clinical validation studies, it is the first test to meet the American Psychiatric Association’s benchmark of 80% sensitivity and 80% specificity for autism screening.
What we do
We specialise in the measurement of specific protein modifications in blood that are linked to autism spectrum disorder.
This research has led to the development of the ASDproteinpattern™ test — a first-of-its-kind blood-based screening tool for autism.
Our patented approach analyses molecular patterns that reflect biochemical differences observed in individuals with ASD.
This innovation enables:
Earlier identification of autism-related biological signatures.
Objective support for clinical diagnosis and research.
Quantitative measures that may correlate with autism severity.
Our scientific work is protected under an international patent portfolio, covering both the ASDproteinpattern™ test and related clinical chemistry markers.
Our Vision
We believe that early and accurate screening is key to supporting better outcomes for children and families.
Our goal is to make autism screening faster, more objective, and more accessible — empowering clinicians and parents with data-driven insights.
Our Research
iDiagnostix’s research builds on years of peer-reviewed scientific studies investigating post-translational protein modifications and their role in neurodevelopmental conditions.
By translating this biochemical understanding into a scalable blood test, we are defining a new frontier in autism diagnostics.
The Test
Type: Blood-based laboratory test
Purpose: Screening tool for autism spectrum disorder
Methodology: Quantitative analysis of specific protein modification patterns
Development: Patented and validated through proprietary clinical research
This test represents a significant advancement in biomarker-driven assessment and may, in future, complement behavioural and developmental screening approaches used by clinicians worldwide.are defining .
Innovation & Ethics
Every innovation we develop is guided by scientific integrity, ethical transparency, and clinical responsibility.
We work within established regulatory frameworks and collaborate with clinical and academic partners to ensure that our diagnostic tools are both robust and responsible.
iDiagnostix Ltd
A biotechnology company dedicated to developing a blood test for autism spectrum disorder